Neurolign Investor Relations Information

This section doesn’t currently include any content. Add content to this section using the sidebar.

Image caption appears here

Add your deal, information or promotional text

Neurolign Technologies™, the global leader in clinical eye-tracking and neuro-functional diagnostic testing, today announced the expansion of an ongoing strategic partnership with the Henry M. Jackson Foundation for the Advancement of Military Medicine. 
  • 1 min read
Diplomats Kate Husband, Doug Ferguson and Tina Onufer were among the first victims of “Havana Syndrome,” a still-unexplained phenomenon, while working at the U.S. embassy in Cuba. Neurolign Dx clinical products were used as the leading technology to aid the doctors, researchers and academics who first diagnosed Havana Syndrome.
  • 1 min read

Recently Featured In:

Investor Relations

Q3 2021 Neurolign Shareholders Meeting

Search